Yi Huang

Yi Huang

University of Pittsburgh

H-index: 39

North America-United States

About Yi Huang

Yi Huang, With an exceptional h-index of 39 and a recent h-index of 25 (since 2020), a distinguished researcher at University of Pittsburgh, specializes in the field of Breast Cancer, Epigenetics, Cancer Pharmacology, Immuno-oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5-and p53/PUMA-mediated cell death

CDK4/6 inhibition suppresses p73 phosphorylation and activates DR5 to potentiate chemotherapy and immune checkpoint blockade

Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance

Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside

EIF3H orchestrates Hippo pathway–mediated oncogenesis via catalytic control of YAP stability

Yi Huang Information

University

Position

School of Medicine

Citations(all)

4316

Citations(since 2020)

1703

Cited By

3239

hIndex(all)

39

hIndex(since 2020)

25

i10Index(all)

53

i10Index(since 2020)

41

Email

University Profile Page

University of Pittsburgh

Google Scholar

View Google Scholar Profile

Yi Huang Skills & Research Interests

Breast Cancer

Epigenetics

Cancer Pharmacology

Immuno-oncology

Top articles of Yi Huang

Title

Journal

Author(s)

Publication Date

Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications

Jun Yin

Tiezheng Gu

Norin Chaudhry

Nancy E Davidson

Yi Huang

2023

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5-and p53/PUMA-mediated cell death

Frontiers in Oncology

Chaoyuan Kuang

Jingshan Tong

Kaylee Ermine

Manbo Cai

Fujun Dai

...

2022/10/12

CDK4/6 inhibition suppresses p73 phosphorylation and activates DR5 to potentiate chemotherapy and immune checkpoint blockade

Cancer research

Jingshan Tong

Xiao Tan

Xiangping Song

Man Gao

Denise Risnik

...

2022/4/1

Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance

Cellular signalling

Zhuan Zhou

Xinxin Song

Junlong Jack Chi

David R Gius

Yi Huang

...

2020/6/1

Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

Theranostics

Weina Ma

Jingjing Sun

Jieni Xu

Zhangyi Luo

Dingwei Diao

...

2020

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside

Darleny Y Lizardo

Chaoyuan Kuang

Suisui Hao

Jian Yu

Yi Huang

...

2020/12/1

EIF3H orchestrates Hippo pathway–mediated oncogenesis via catalytic control of YAP stability

Cancer research

Zhuan Zhou

Honghong Zhou

Luca Ponzoni

Aiping Luo

Rui Zhu

...

2020/6/15

See List of Professors in Yi Huang University(University of Pittsburgh)